Mera Pharmaceuticals Announces Broker Agreement

Mera Pharmaceuticals, a leader in the commercial cultivation of microalgae, announced that it has received its initial order from a well-established, international broker that Mera has engaged to sell its products to the nutraceutical industry. The order is for Mera's AstaFactor brand astaxanthin, a powerful antioxidant and anti-inflammatory. Mera's chief executive, Dan Beharry, considers the development as a positive step for the Hawaii-based company.

mysan.de (http://www.mysan.de/article97568.html)